Conflicto de intereses Eva Vilarrasa ha recibido honorarios por consultora y/o como oradora y/o para viajes y/o ha participado en ensayos clnicos patrocinados por Abbvie, Almirall, Amgen, Boehringer Ingelheim, Bristol-Meyers Squibb, Celgene, Gebro, Isdin, Janssen, LEO Pharma, Lilly, Merck Serono, MSD, Novartis, Pfizer, Roche, Sandoz, Sanofi y UCB
A 2021 meta-analysis found that Lipo C combined with a 500-calorie daily deficit produced 1525% greater fat loss over 12 weeks compared to diet alone, but patients who received injections without dietary restriction showed no significant weight loss
The two most significant incretin hormones are GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide)
Semaglutide GLP-1 has demonstrated superior efficacy for sustained weight loss and improvements in metabolic parameters
Life , 13 (10), 2058
Over 17,600 participants received either Wegovy or placebo